Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
09/1990
09/21/1990CA2012720A1 Genetically engineered human cholinesterases
09/20/1990DE3909329A1 20-alkyl-13,14,18,18,19,19-hexadehydro-3- oxa-isocarbacyclin-derivate und ihre pharmazeutische verwendung 20-alkyl-13,14,18,18,19,19-hexadehydro-3-oxa-isocarbacyclin derivatives and their pharmaceutical use
09/19/1990EP0388188A1 Benzoxepin derivatives
09/19/1990EP0387613A1 Thienodiazepines
09/19/1990EP0387610A2 Substituted (quinolin-2-yl methoxy)phenyl-N,N'-sulphonyl ureas, processes for their preparation and their use in medicines
09/19/1990EP0342206A4 Human interleukin-3 proteins
09/19/1990CN1009645B T-oxa-dicyclo heptane subst. diamides and the same kind of pg analogue
09/18/1990US4957923 Diuretic or antihypertensive composition
09/18/1990US4957864 Thromrolytic activity; isolated from a human kidney or blood vessel
09/18/1990CA2012411A1 Process for preparing enantiomerically pure hetrazepines
09/16/1990WO1990010705A2 Production and purification of recombinant human interleukin-3 and muteins thereof
09/16/1990CA2028827A1 Production and purification of recombinant human interleukin-3 and muteins thereof
09/14/1990CA2011952A1 Leukotriene-inhibiting substituted (quinolin-2-yl-methoxy) phenyl-n,n'-sulphonylureas
09/12/1990EP0387140A1 Composition with an anti-aggregatory effect on blood platelets for therapeutical use
09/12/1990EP0387000A2 Medicament for the treatment of thrombus, inflammation and high blood pressure
09/12/1990EP0386675A2 Xanthine derivatives
09/12/1990EP0386076A1 Phosphoryled derivatives of cardiodilatine/anf peptides.
09/11/1990WO1990010447A1 Platelet function-inhibiting composition which can be used in therapy
09/11/1990US4956349 Anti-inflammatory factor, method of isolation, and use
09/11/1990CA1273942A1 Derivatives of imidazole, their preparation and utilisation, and pharmaceutical compositions containing these derivatives
09/11/1990CA1273870A1 Composition with cosmetic or pharmaceutical use containing niosomes and at least one watersoluble polyamide and process for the preparation of the said composition
09/07/1990WO1990010649A1 Serpin resistant chymotrypsin superfamily proteases, particularly pai-1 resistant +-pa, complementary inhibitor mutants; compositions; genes; expression
09/05/1990EP0385850A2 Benzimidazole and azabenzimidazole derivatives, process for their preparation, synthesis intermediates, pharmaceutical compositions containing them, useful for the treatment of cardiovascular diseases and duodenal ulcers
09/05/1990EP0385712A2 A peptide for use in the manufacture of a composition for prevention or treatment of a condition susceptible to treatment with a platelet aggregation inhibition agent
09/05/1990EP0385490A1 2-picolylamine derivates
09/05/1990EP0341300A4 Stimulation of stem cell growth by the bryostatins
09/05/1990EP0246439B1 Sterile plasma substitute
09/04/1990US4954524 Hypotensive, anticoagulant, cardiovascular
09/04/1990US4954499 Display positive inotropic properties, vasodilators, antithrombotic agent
09/04/1990US4954498 Hypotensive agents, anticoagulants, cardiovascular disorders
09/04/1990US4954491 Method of treatment using 18-cyanoprogesterone derivatives
09/04/1990US4954488 Method of treating hyperaldosteronism using 17β-cyclopropylaminoandrostene derivatives
09/04/1990CA1273577A1 Prostacyclins, their analogues or prostaglandins and thromboxane anagonists for the treatment of thrombotic and thrombo-embolic syndromes
09/03/1990CA2011222A1 Benzimidazole and azabenzimi-dazole derivatives, their methods of preparation, synthesis intermediates and pharmaceutical compositions in which they are present and which are useful especially for the treatment of cardiovascular diseases and duodenal ulcers
09/02/1990CA2011277A1 2-picolylamine derivatives
08/1990
08/29/1990EP0384747A1 Pharmaceutical or veterinary preparations of substituted hexenoic acid derivatives
08/29/1990EP0384594A1 Anti-inflammatory aryl derivatives
08/29/1990EP0384421A2 Use of PAF antagonists in the treatment of pathologic changes of the blood gas
08/29/1990EP0384362A2 Glycinderivatives
08/29/1990EP0384302A2 Use of ubenimex in the manufacture of a medicament for treating myelodysplastic syndrome
08/29/1990EP0384122A2 Mutants of human antithrombin III
08/29/1990EP0383764A1 Bovine granulocyte-macrophage colony stimulating factor.
08/28/1990WO1990010003A1 PREPARATION OF 5,6,7-TRINOR-4,8-INTER-m-PHENYLENE PGI2 DERIVATIVES
08/28/1990US4952583 Diuretic hypotensive agents
08/28/1990US4952571 Treating heart failure or asthma
08/28/1990CA1273294A1 Production of a-a cross-linked hemoglobins in high yield
08/24/1990WO1990009997A1 Novel benzimidazole derivatives
08/24/1990CA2050908A1 Benzimidazole derivatives
08/23/1990WO1990009377A1 Alcaline salts of 2-(2,6-dimethyl-3,5-diethoxycarbonyl-1,4-dihydropyridine-4-carboxamido) ethane sulphonic acid and method of obtaining them
08/23/1990WO1990009194A1 Use of il-7 in providing medications for stimulation of platelet production
08/23/1990WO1990009183A1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections
08/23/1990CA2010600A1 Use of paf-antagonists for treating pathological changes in blood gas
08/22/1990EP0383645A1 Process to prepare a very pure antihaemophilic factor.
08/22/1990EP0383533A1 Therapeutic medicament for thrombosis and method for preparation thereof
08/22/1990EP0383417A1 Vampire bat salivary Plasminogen activator vPA-alpha 1
08/22/1990EP0382935A1 2-(1H-imidazol-4(5)-yl)-3,4-dihydro-2H-1-benzothiopyran
08/22/1990CN1044815A Process for preparing 3,18-dihydroxy-9,13-epoxylabdanum derivatives
08/21/1990US4950483 Implantation, fibrils are not cross-linked
08/18/1990WO1990010081A1 Soluble analogs of thrombomodulin
08/18/1990CA2046906A1 Soluble analogs of thrombomodulin
08/16/1990EP0382451A2 Viper venom Polypeptides and variants
08/16/1990EP0382381A1 Treatment of leukocyte dysfunction with GM-CSF
08/16/1990EP0382380A1 Pyridinium Nitrate, its production and use
08/16/1990EP0382174A1 Derivative of a tissue plasminogen activator
08/16/1990DE4003844A1 Neue cyclosporin enthaltende galenische formulierungen New cyclosporin-containing pharmaceutical formulations
08/15/1990CN1044656A Pyrazolopyridine compound and processes for preparation thereof
08/15/1990CA2009531A1 Therapeutic medicament for thrombosis and method for preparation thereof
08/14/1990WO1990009438A1 Novel thrombolytic
08/14/1990US4948809 Sulphonylalkylamines, processes for the preparation thereof and pharmaceutical compositions containing them
08/14/1990US4948808 Enzyme inhibitors
08/14/1990US4948795 Platelet activating factor antagonists
08/14/1990CA1272723A1 Process for the preparation of new phenol derivatives
08/09/1990WO1990008772A1 Processes for producing polypeptide inhibitors of platelet activation and methods, combinations and compositions using them
08/09/1990WO1990008557A1 Pharmaceutical formulations of plasminogen activator proteins
08/09/1990WO1990008554A1 Treatment of leukocyte dysfunction with gm-csf
08/09/1990DE4003392A1 Thromboxan a(pfeil abwaerts)2(pfeil abwaerts)-rezeptor-antagonisten zur verwendung bei der behandlung von bluthochdruck Thromboxane A (down arrow) 2 (down arrow) receptor antagonists for use in the treatment of high blood pressure
08/08/1990WO1990009437A1 Tissue plasminogene activator derivative
08/08/1990EP0381640A1 New thrombolytic compositions
08/08/1990EP0381490A2 Gene therapy using stromal cells
08/08/1990EP0381331A2 Gene sequences encoding modified residues situated in the protease domain of tpa
08/08/1990EP0381033A1 Carboxylic-acid and sulphonic-acid amides
08/08/1990EP0221977B1 Depolymerized hexosaminoglucan sulfates endowed with an antithrombotic, fibrinolytic, antiinflammatory activity, their process of preparation and related pharmaceutical compositions
08/08/1990CN1009096B Prepn. of depolymerizing sulfuric acid aminohexose polyose having antithrombotic, solution fibrin and antiphlogistic activity
08/07/1990US4946785 Method of suppressing the thermal degradation of urokinase
08/07/1990CA2009390A1 Viper venom polypeptides and variants
08/06/1990CA2007896A1 Method of treating hypertension using a thromboxane a2 receptor antagonist and new combinations
08/03/1990CA2009201A1 Anti-inflammatory aryl derivatives
08/01/1990EP0380443A2 Monoclonal antibodies specific for thrombin hirudin
08/01/1990EP0380392A2 Derivatives of benzocycloalkenyl dihydroxyalkanoic acids, methods of making them and phrmaceuticals containing them
08/01/1990EP0380155A1 8,9-Annelated-1,2,3,4-tetrahydro-beta-carboline derivatives
08/01/1990EP0380135A2 Use of 18-cyano-progesterone derivatives as aldosterone inhibitors
08/01/1990EP0380063A1 1,2-cyclohexylaminoaryl amides useful as analgesic agents
08/01/1990EP0379979A1 Pyrazolopyridine compounds and processes for preparation thereof
08/01/1990EP0379890A1 New tissue plasminogen activator
07/1990
07/31/1990US4945106 Prostaglandins
07/31/1990CA2008311A1 Carboxylic - and sulfonic acid amides
07/31/1990CA1272128A1 Thrombin preparations
07/28/1990CA2045692A1 Processes for producing polypeptide inhibitors of platelet activation and methods, combinations and compositions using them
07/28/1990CA2045562A1 Pharmaceutical formulations of plasminogen activator proteins
07/26/1990WO1990008775A1 POLYPEPTIDES HAVING A HUMAN β ADRENERGIC RECEPTOR ACTIVITY, AND PLAYING A ROLE IN LIPOLYTIC RESPONSE, NUCLEIC ACIDS CODING FOR THESE POLYPEPTIDES AND USE OF SAID POLYPEPTIDES FOR SCREENING SUBSTANCES WHICH ACT ON THESE POLYPEPTIDES
1 ... 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 ... 671